M

MirZyme Therapeutics

10 employees

MirZyme Therapeutics is an innovative biopharmaceutical company that focuses on the development and commercialisation of diagnostics and drugs for women with pregnancy complications, specifically preeclampsia

Investor insights

Funding rounds participated in

$2.1M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

2016

Funding rounds raised

Total raised

$2.1M

from investors over 1 rounds

M

MirZyme Therapeutics raised $2.1M on September 10, 2018